Never a mention of RVX in any of the publication I find it a little strange that Steven Nissen has rarely mentioned RVX as an alternative HDL trial to the current CEPT trials. It would be nice if we had some media exposure. I wonder if Russo and Partners might have been brought on just for this reason.